OpenVSafe by OpenVAERS
Search V-safe

PAB-36357-98631

1 vaccination 6 coded responses 14 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
840 / UT
Registered
2021-03-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-29
    Registered in v-safe
  3. 2021-03-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Joint swelling, Peripheral swelling, Swelling, Tenderness — Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activities
    Free text: Swelling and tenderness of wrist, hands, fingers and angles, feet and toes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains
    Adult check-in
  5. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Joint pains
    Adult check-in
  6. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains
    Adult check-in
  7. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-03
    Health check-in — day 7, dose 1
    Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-10
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Feeling of despair, Illness — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Very painful joints, Feeling of sickness, hopelessness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-10
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-04-17
    Survey response — day 21, dose 1
    MedDRA: Arthralgia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Extreme joint pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-17
    Report sent to call center — day 21, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-04-24
    Survey response — day 28, dose 1
    MedDRA: Arthralgia, Myalgia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Persistent joint and muscle pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-24
    Report sent to call center — day 28, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-01
    Health check-in — day 35, dose 1
    Feeling: Poor
    Adult check-in
  16. 2021-05-08
    Health check-in — day 42, dose 1
    Feeling: Poor
    Adult check-in
  17. 2021-06-26
    Health check-in — 3 months, dose 1
    Feeling: Poor
    Adult check-in
  18. 2021-09-25
    Survey response — 6 months, dose 1
    MedDRA: Arthralgia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Expanded and continued arthralgia
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-09-25
    Report sent to call center — 6 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2021-09-28
  21. 2021-09-29
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  22. 2022-03-27
    Survey response — 12 months, dose 1
    MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Pervasive arthritic vaccine injury
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-03-27
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  24. 2022-03-28
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12021-03-27Pfizer-BioNTech

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-29

Systemic reaction (other): Swelling and tenderness of wrist, hands, fingers and angles, feet and toes.

Release 7 — day 14, dose 1

2021-04-10

Symptoms: Very painful joints, Feeling of sickness, hopelessness

Release 7 — day 21, dose 1

2021-04-17

Symptoms: Extreme joint pain

Release 7 — day 28, dose 1

2021-04-24

Symptoms: Persistent joint and muscle pain

Release 9 — 6 months, dose 1

2021-09-25

Symptoms: Expanded and continued arthralgia

Release 11 — 12 months, dose 1

2022-03-27

Symptoms: Pervasive arthritic vaccine injury

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDFeeling of despair ✓ ✓ ✓
SDIllness ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDPre-existing disease · · ✓
SROJoint swelling ✓ ✓ ✓
SROPeripheral swelling ✓ ✓ ✓
SROSwelling ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release